SCHEMBL7218451

SCHEMBL7218451

C[CH]c1nc2c(F)cccc2s1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 9/20 0.56
▸ RAB9A P51151 9/20 0.54
▸ NPC1 O15118 8/20 0.54
▸ ALDH1A1 P00352 7/20 0.54
▸ GAA P10253 7/20 0.54
▸ MEN1 O00255 7/20 0.54
▸ KMT2A Q03164 7/20 0.54
▸ HPGD P15428 6/20 0.54
▸ KDM4E B2RXH2 6/20 0.54
▸ LMNA P02545 5/20 0.54
▸ PRNP P04156 1/20 0.54
▸ MAPT P10636 6/20 0.51
▸ MAPK1 P28482 1/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ CASP3 P42574 2/20 0.46
▸ SENP8 Q96LD8 2/20 0.46
▸ SENP7 Q9BQF6 2/20 0.46
▸ SENP6 Q9GZR1 2/20 0.46
▸ TSHR P16473 1/20 0.46
▸ POLB P06746 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31595929 0.82 SMN1; SMN2 (0.56) SMN1; SMN2RAB9ANPC1ALDH1A1GAA
SCHEMBL25366862 0.82 SMN1; SMN2 (0.56) SMN1; SMN2RAB9ANPC1ALDH1A1GAA
SCHEMBL14127134 0.80 ALDH1A1 (0.58) SMN1; SMN2RAB9ANPC1ALDH1A1GAA
SCHEMBL2623678 0.76 SMN1; SMN2 (0.61) SMN1; SMN2RAB9ANPC1ALDH1A1GAA
SCHEMBL5892826 0.75 SMN1; SMN2 (0.66) SMN1; SMN2RAB9ANPC1ALDH1A1GAA
SCHEMBL3077601 0.73 SMN1; SMN2 (0.67) SMN1; SMN2RAB9ANPC1ALDH1A1GAA
SCHEMBL102844 0.72 SMN1; SMN2 (1.00) SMN1; SMN2RAB9ANPC1ALDH1A1GAA
SCHEMBL2634141 0.72 SMN1; SMN2 (0.61) SMN1; SMN2RAB9ANPC1ALDH1A1GAA
SCHEMBL7698118 0.72 SMN1; SMN2 (0.61) SMN1; SMN2RAB9ANPC1ALDH1A1GAA
SCHEMBL7216401 0.72 SMN1; SMN2 (0.61) SMN1; SMN2RAB9ANPC1ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1193020-C Process for preparing amic acid esters IHARA CHEMICAL IND CO (JP) 2005-03-16 — — CN disclosed
US-6576765-B2 Process for preparing amic acid esters IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2003-06-10 — — US disclosed
US-20030032667-A1 PROCESS FOR PREPARING AMIC ACID ESTERS IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2003-02-13 — — US disclosed
CN-1366523-A Process for preparing amic acid esters IHARA CHEMICAL IND CO (JP) 2002-08-28 — — CN disclosed
EP-1182199-A1 PROCESS FOR PREPARING AMIC ACID ESTERS IHARA CHEMICAL INDUSTRY Co., Ltd. (JP) 2002-02-27 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030032667-A1 PROCESS FOR PREPARING AMIC ACID ESTERS MCCC2, EMC1, GANC SMN1; SMN2 4168/4885RAB9A 774/4885NPC1 2798/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback